These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 19116975

  • 1. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
    Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ.
    Arthritis Rheum; 2009 Jan 15; 61(1):46-51. PubMed ID: 19116975
    [Abstract] [Full Text] [Related]

  • 2. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H, Biber D, Heins S, Horneff G.
    J Rheumatol; 2005 Sep 15; 32(9):1832-6. PubMed ID: 16142884
    [Abstract] [Full Text] [Related]

  • 3. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Becker ML, van Haandel L, Gaedigk R, Lasky A, Hoeltzel M, Stobaugh J, Leeder JS.
    Arthritis Rheum; 2010 Jun 15; 62(6):1803-12. PubMed ID: 20191581
    [Abstract] [Full Text] [Related]

  • 4. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
    Bartoli M, Tarò M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, Magnani A, Gasparini C, Martini A, Ravelli A.
    Ann Rheum Dis; 2008 Mar 15; 67(3):370-4. PubMed ID: 17660217
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
    Céspedes-Cruz A, Gutiérrez-Suárez R, Pistorio A, Ravelli A, Loy A, Murray KJ, Gerloni V, Wulffraat N, Oliveira S, Walsh J, Penades IC, Alpigiani MG, Lahdenne P, Saad-Magalhães C, Cortis E, Lepore L, Kimura Y, Wouters C, Martini A, Ruperto N, Pediatric Rheumatology International Trials Organization (PRINTO).
    Ann Rheum Dis; 2008 Mar 15; 67(3):309-14. PubMed ID: 17875547
    [Abstract] [Full Text] [Related]

  • 6. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan 15; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 7. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
    Masi L, Ricci L, Zulian F, Del Monte F, Simonini G, Capannini S, De Martino M, Brandi ML, Falcini F.
    J Rheumatol; 2009 Oct 15; 36(10):2308-13. PubMed ID: 19684155
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2004 Jul 15; 50(7):2191-201. PubMed ID: 15248217
    [Abstract] [Full Text] [Related]

  • 9. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
    Bulatovic M, Heijstek MW, Van Dijkhuizen EH, Wulffraat NM, Pluijm SM, de Jonge R.
    Ann Rheum Dis; 2012 Sep 15; 71(9):1484-9. PubMed ID: 22473625
    [Abstract] [Full Text] [Related]

  • 10. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I.
    Arthritis Rheum; 2000 Aug 15; 43(8):1849-57. PubMed ID: 10943876
    [Abstract] [Full Text] [Related]

  • 11. The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
    Becker ML, Gaedigk R, van Haandel L, Thomas B, Lasky A, Hoeltzel M, Dai H, Stobaugh J, Leeder JS.
    Arthritis Rheum; 2011 Jan 15; 63(1):276-85. PubMed ID: 20954192
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
    Foeldvari I, Wierk A.
    J Rheumatol; 2005 Feb 15; 32(2):362-5. PubMed ID: 15693100
    [Abstract] [Full Text] [Related]

  • 13. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
    Dolezalová P, Krijt J, Chládek J, Nemcová D, Hoza J.
    Rheumatology (Oxford); 2005 Jan 15; 44(1):74-9. PubMed ID: 15454631
    [Abstract] [Full Text] [Related]

  • 14. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
    de Thurah A, Nørgaard M, Johansen M, Stengaard-Pedersen K.
    Scand J Rheumatol; 2010 Jan 15; 39(1):19-25. PubMed ID: 20132066
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S, Liebert UG, Borte M, Sack U.
    Rheumatology (Oxford); 2009 Feb 15; 48(2):144-8. PubMed ID: 19074187
    [Abstract] [Full Text] [Related]

  • 16. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
    Ortiz-Alvarez O, Morishita K, Avery G, Green J, Petty RE, Tucker LB, Malleson PN, Cabral DA.
    J Rheumatol; 2004 Dec 15; 31(12):2501-6. PubMed ID: 15570658
    [Abstract] [Full Text] [Related]

  • 17. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R.
    Harefuah; 1998 Dec 01; 135(11):509-11, 567. PubMed ID: 10911466
    [Abstract] [Full Text] [Related]

  • 18. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M, Kremer J.
    Arthritis Rheum; 2004 Sep 01; 50(9):2766-74. PubMed ID: 15457444
    [Abstract] [Full Text] [Related]

  • 19. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
    De Benedetti F, Meazza C, Vivarelli M, Rossi F, Pistorio A, Lamb R, Lunt M, Thomson W, Ravelli A, Donn R, Martini A, British Paediatric Rheumatology Study Group.
    Arthritis Rheum; 2003 May 01; 48(5):1398-407. PubMed ID: 12746913
    [Abstract] [Full Text] [Related]

  • 20. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial.
    Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, van Rossum MA, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Pediatric Rheumatology International Trials Organisation (PRINTO).
    Ann Rheum Dis; 2010 Aug 01; 69(8):1479-83. PubMed ID: 20525842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.